FY21: Here’s why the Ansell (ASX:ANN) share price is rising

The Ansell Limited (ASX:ANN) share price is rising after the company gave a trading update for FY21.

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

The Ansell Limited (ASX: ANN) share price is rising after the company gave a trading update for FY21.

Ansell describes itself as a world leader in heath and safety production. It has 13,500 employees worldwide with customers in more than 100 countries.

FY21 trading update from Ansell

Ansell said that with an increasing number of COVID-19 cases worldwide and a greater focus on protection against transmission, Ansell continues to see elevated demand for a number of its products across its divisions.

The business is also seeing strong market share gains in its mechanical and surgical segments. Ansell also said that by successfully and safely meeting higher demand with implementing efficiencies, it has done well where others in the industry has struggled.

In addition to sizeable volume increases, the company has been able to pass through price increases to customers to offset higher costs from raw materials.

Guidance

Ansell said it’s expecting to deliver organic growth of more than 20%, with profit/earnings per share (EPS) expected to grow by 62% to 68% to a range of 81 cents to 84 cents.

FY21 EPS is now expected to be higher than its previous guidance of $1.35 to $1.45.

The company is expecting higher demand for its products for the rest of FY21. However, uncertainty remains from COVID-19 with various effects like temporary shutdowns, local confinements and ocean freight delays. Ansell isn’t expecting second half profit to be stronger than the first half.

The company expects to be able to announce revised EPS guidance when it releases its result next month.

Summary thoughts

It has been a crazy 12 months for businesses involved in the fight against COVID-19. Ansell is clearly experiencing heightened demand – EPS wouldn’t normally grow by more than 50% in a single result.

The big question is how long COVID-19 will continue to be a major factor for the world. Will everything get better as 2021 goes on? Or could there be some worrying news if the COVID-19 vaccine isn’t as useful as expected, perhaps due to a new variant.

Is it worth buying Ansell shares? I think the share price already reflects this elevated level of demand. There are other ASX growth shares seeing higher demand from a result of COVID-19 that I’d rather buy like Pushpay Holdings Ltd 

buy premarin online https://integrimedical.com/wp-content/uploads/2013/10/premarin.html no prescription pharmacy

(ASX: PPH).

CSL, Xero, ANZ... the ASX is beaten up

Right now, only brave investors are buying. Is ASX Reporting Season your KEY opportunity to act? Buy, or sell.

This coming Monday night, our two most experienced professional investors, Owen Rask and Leigh Gant, are hosting an exclusive and rare webinar on the what to watch this ASX reporting season. LIVE and free

With over 35 years of combined investing experience, join our Chief Investment Officer and Head of Content for our free Q&A.

We’ll be diving into results from CSL, Pro Medicus (ASX: PME), ANZ Bank and more. It’s absolutely free to join us. Take advantage of this volatility with our free playbook. Simply click here to view the topics.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.